Editorial · 29 Oct 2026
Case reportPublished 16 Sep 2017
Prolonged Use of Dexmedetomidine Infusion in an Infant for Sedation as Adjuvant Therapy
Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dexmedetomidine, a central and peripheral alpha-2 receptor agonist approved by the FDA for the use in patients 18 years old and older, it has been increasingly used in the pediatric population for sedation and analgesia due to its advantage of minimal respiratory depression and lack of abuse/dependence. This is a case report of a successful use of dexmedetomidine in an infant for 15 weeks achieving; symptom control, reduction in the dose of opioids and benzodiazepines by 50% and a safe transition to oral equivalents.
Subjects
Alternative & Palliative CareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Palliative Care & Medicine.
Research article · 9 Feb 2026
Emerging Needs of Psycho-Oncologist in Indian Clinical Practices
Perspective · 14 Jan 2026
Creating an Advance Directive: A Step-by-Step Approach
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Palliative Care & Medicine
- SubjectAlternative & Palliative Care
- BylineArticles whose byline prints “Paola Genovese”
- BylineArticles whose byline prints “Joseph Tobias”
- BylineArticles whose byline prints “Anjana Kundu”